These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 1933868)
1. Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation. Mani C; Kupfer D Cancer Res; 1991 Nov; 51(22):6052-8. PubMed ID: 1933868 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation. Mani C; Hodgson E; Kupfer D Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125 [TBL] [Abstract][Full Text] [Related]
4. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins. Juedes MJ; Bulger WH; Kupfer D Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703 [TBL] [Abstract][Full Text] [Related]
5. Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin. Parte P; Kupfer D Drug Metab Dispos; 2005 Oct; 33(10):1446-52. PubMed ID: 15987777 [TBL] [Abstract][Full Text] [Related]
6. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy. Dehal SS; Brodie AM; Kupfer D Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571 [TBL] [Abstract][Full Text] [Related]
7. Effect of cytochrome P-450 and flavin-containing monooxygenase modifying factors on the in vitro metabolism of amiodarone by rat and rabbit. Young RA; Mehendale HM Drug Metab Dispos; 1987; 15(4):511-7. PubMed ID: 2888625 [TBL] [Abstract][Full Text] [Related]
8. Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. Mani C; Pearce R; Parkinson A; Kupfer D Carcinogenesis; 1994 Dec; 15(12):2715-20. PubMed ID: 8001226 [TBL] [Abstract][Full Text] [Related]
9. CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver. Dehal SS; Kupfer D Cancer Res; 1997 Aug; 57(16):3402-6. PubMed ID: 9270005 [TBL] [Abstract][Full Text] [Related]
10. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction. Katchamart S; Stresser DM; Dehal SS; Kupfer D; Williams DE Drug Metab Dispos; 2000 Aug; 28(8):930-6. PubMed ID: 10901703 [TBL] [Abstract][Full Text] [Related]
11. Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins. Dehal SS; Kupfer D Cancer Res; 1996 Mar; 56(6):1283-90. PubMed ID: 8640815 [TBL] [Abstract][Full Text] [Related]
12. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase. Kedderis GL; Rickert DE Drug Metab Dispos; 1985; 13(1):58-61. PubMed ID: 2858378 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of ketoconazole and deacetylated ketoconazole by rat hepatic microsomes and flavin-containing monooxygenases. Rodriguez RJ; Acosta D Drug Metab Dispos; 1997 Jun; 25(6):772-7. PubMed ID: 9193882 [TBL] [Abstract][Full Text] [Related]
14. Flavin-containing monooxygenase-mediated N-oxidation of the M(1)-muscarinic agonist xanomeline. Ring BJ; Wrighton SA; Aldridge SL; Hansen K; Haehner B; Shipley LA Drug Metab Dispos; 1999 Oct; 27(10):1099-103. PubMed ID: 10497134 [TBL] [Abstract][Full Text] [Related]
15. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate. Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177 [TBL] [Abstract][Full Text] [Related]
16. Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes. Onderwater RC; Commandeur JN; Menge WM; Vermeulen NP Chem Res Toxicol; 1999 May; 12(5):396-402. PubMed ID: 10328749 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole. Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258 [TBL] [Abstract][Full Text] [Related]
18. Sulfoxidation of mercapturic acids derived from tri- and tetrachloroethene by cytochromes P450 3A: a bioactivation reaction in addition to deacetylation and cysteine conjugate beta-lyase mediated cleavage. Werner M; Birner G; Dekant W Chem Res Toxicol; 1996; 9(1):41-9. PubMed ID: 8924615 [TBL] [Abstract][Full Text] [Related]
19. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases. Weber GF; Waxman DJ Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of monooxygenase-mediated covalent binding of methoxychlor in human and rat liver microsomes. Bulger WH; Kupfer D Drug Metab Dispos; 1989; 17(5):487-94. PubMed ID: 2573491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]